Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keybanc Initiates Coverage On ICU Medical with Overweight Rating, Announces Price Target of $134

Author: Benzinga Newsdesk | February 06, 2024 07:56am
Keybanc analyst Brett Fishbin initiates coverage on ICU Medical (NASDAQ:ICUI) with a Overweight rating and announces Price Target of $134.

Posted In: ICUI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist